Medicine and Dentistry
AMPK Signaling
100%
AMP-Activated Protein Kinase
100%
Cell Signaling Pathway
100%
Melanoma
100%
Vemurafenib
33%
Glycon
33%
Squamous Cell Carcinoma
33%
Cell Proliferation
16%
Cancer Growth
16%
Maturity Onset Diabetes of the Young
16%
Phenformin
16%
B Raf Kinase Inhibitor
16%
Keratoacanthoma
16%
Antineoplastic Activity
16%
Tumor Progression
16%
B Raf Kinase
16%
Targeted Therapy
16%
Malignant Neoplasm
16%
Cancer Therapy
16%
Clinical Trial
16%
Drug Resistance
16%
Tumor Suppressor Protein
16%
Carcinogenesis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Malignant Neoplasm
33%
Metformin
33%
Squamous Cell Carcinoma
33%
Vemurafenib
33%
Preclinical Study
16%
Mouse Model
16%
B Raf Kinase
16%
Tumor Growth
16%
Clinical Trial
16%
Neoplasm
16%
Drug Resistance
16%
Cancer Growth
16%
B Raf Kinase Inhibitor
16%
Keratoacanthoma
16%
Phenformin
16%
Tumor Suppressor Protein
16%
Non Insulin Dependent Diabetes Mellitus
16%
Carcinogenesis
16%